A Phase III, Randomized, Multicenter, Parallel-group Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals;   Drug: ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK;   Drug: Placebo Sponsor:   Respirent Pharmaceuticals Co Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2018 Category: Research Source Type: clinical trials

A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Condition:   Asthma Interventions:   Drug: Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals;   Drug: ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK;   Drug: Placebo Sponsor:   Respirent Pharmaceuticals Co Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 18, 2018 Category: Research Source Type: clinical trials

A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50
Condition:   Asthma Interventions:   Drug: Test Product;   Drug: Reference Product;   Drug: Placebo Sponsor:   Amneal Ireland Limited Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 20, 2018 Category: Research Source Type: clinical trials